The School SPIT Study - Elementary Schools in High COVID-19 Incidence Regions
NCT05055492 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2023-05-25
Summary
This study will conduct an evaluation of a program that is being implemented SickKids / Toronto Public Health that provides take-home saliva testing kits in schools. Operationally, there is a planned randomization so that all schools have an equitable chance to receive the intervention at various time periods during the planned operational roll-out, which will require a staggered implementation consistent with the stepped-wedge study design. This study will leverage this chance implementation to do a robust evaluation of the public health intervention. Schools that are not being rolled out to week one, will begin in the "control phase" (testing at an assessment center, primary care or acute care center) and transition to the program "intervention phase" (take home saliva kits available at schools) at a randomly assigned time (wedge) over a 6-week period with all schools receiving the program by the end of the study. The investigators will evaluate the impact of the program on SARS-CoV-2 case identification in schools.
Conditions
- SARS-CoV2 Infection
Interventions
- DIAGNOSTIC_TEST
-
Take home saliva kits
Saliva kits will be made available at schools for pick up to support symptomatic testing using PCR for students, staff and family members.
Sponsors & Collaborators
-
The Hospital for Sick Children
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-09-14
- Primary Completion
- 2021-11-01
- Completion
- 2022-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Prevalence of Latent Tuberculosis in High Risk Children
NCT03910946 ·Status: UNKNOWN
-
Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests
NCT02252198 ·Status: COMPLETED
-
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
NCT05007795 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Acceptability and Feasibility of Home-based TB Testing
NCT04973371 ·Status: COMPLETED ·Phase: NA
-
Rapid Diagnosis of Pulmonary Tuberculosis
NCT00608790 ·Status: UNKNOWN ·Phase: NA
-
Diagnosing Tuberculosis in HIV Infected Children in Peru
NCT00054769 ·Status: COMPLETED
-
Nurse-Led, Symptom-Based Screening of Household Child Contacts of Tuberculosis Index Cases
NCT03074799 ·Status: COMPLETED ·Phase: NA
-
Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa
NCT02808507 ·Status: COMPLETED ·Phase: NA
-
ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa
NCT06214910 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Accuracy of a Novel Xpert Cartridge
NCT02251327 ·Status: COMPLETED
-
Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2)
NCT05405296 ·Status: ACTIVE_NOT_RECRUITING
-
High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
NCT04521803 ·Status: RECRUITING ·Phase: PHASE2
-
Promoting Adherence to TB Regimens in Latino Adolescents
NCT00005738 ·Status: COMPLETED
-
Integrated Discovery and Development of Innovative TB Diagnostics
NCT06624501 ·Status: COMPLETED
-
Performance Evaluation of TB Breath- and Cough-testing Platforms
NCT03025516 ·Status: UNKNOWN
-
Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)
NCT05989802 ·Status: RECRUITING ·Phase: NA
-
Validation of 'Corona-T-test' for Assessment of SARS-COV-2-specific T-cell Response After COVID-19 or Vaccination
NCT05165719 ·Status: COMPLETED
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
Gene Xpert Diagnosis of TB Using Tracheal Aspirates From Intensive Care Unit (ICU) Patients
NCT01530568 ·Status: COMPLETED ·Phase: NA
-
Infant TB Infection Prevention Study
NCT02613169 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease
NCT05981495 ·Status: UNKNOWN
-
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
NCT03512249 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons
NCT02538952 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Active Case Finding of Household Contacts in a Routine Tuberculosis (TB) Control Program
NCT02174380 ·Status: UNKNOWN ·Phase: NA
-
Assessing the Ability of the T-SPOT®.TB Test
NCT03929705 ·Status: COMPLETED